About Invivyd
Invivyd is a company based in Waltham (United States) founded in 2022.. The company has 99 employees as of December 31, 2024. Invivyd offers products and services including Antibody Therapies and Invymab. Invivyd operates in a competitive market with competitors including Blue Rock Therapeutics, Impel Pharmaceuticals, CellCarta, Ascend and RiboPro, among others.
- Headquarter Waltham, United States
- Employees 99 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Invivyd, Inc.
-
Annual Revenue
$25.38 M0as on Dec 31, 2024
-
Net Profit
$-169.93 M14.46as on Dec 31, 2024
-
EBITDA
$-173.76 M15.55as on Dec 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
99
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Invivyd
Invivyd is a publicly listed company on the NASDAQ with ticker symbol IVVD in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Invivyd
Invivyd offers a comprehensive portfolio of products and services, including Antibody Therapies and Invymab. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Monoclonal antibodies for preventing and treating viral diseases.
Antibody-based solutions targeting evolving viral threats.
Unlock access to complete
Unlock access to complete
Leadership Team
15 people
Legal and Compliance
2 people
Human Resources and Administration
2 people
Data Analysis and Operations Team
2 people
Software Development Team
2 people
Product Management Team
2 people
Principal Team
1 people
Consultant Team
1 people
Unlock access to complete
Funding Insights of Invivyd
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Invivyd
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Invivyd
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Invivyd Comparisons
Competitors of Invivyd
Invivyd operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blue Rock Therapeutics, Impel Pharmaceuticals, CellCarta, Ascend and RiboPro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Stem cell therapies are developed for cardiovascular and neurological diseases.
|
|
| domain | founded_year | HQ Location |
Transformative therapies are developed and commercialized through specialized services.
|
|
| domain | founded_year | HQ Location |
Histopathology and genomics services are offered by the CRO.
|
|
| domain | founded_year | HQ Location |
Online insurance payments and premium financing are enabled for businesses.
|
|
| domain | founded_year | HQ Location |
Online supplier and developer of RNA based products
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Invivyd
Frequently Asked Questions about Invivyd
When was Invivyd founded?
Invivyd was founded in 2022.
Where is Invivyd located?
Invivyd is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
How many employees does Invivyd have?
As of Dec 31, 2024, the latest employee count at Invivyd is 99.
What is the annual revenue of Invivyd?
Annual revenue of Invivyd is $25.38M as on Dec 31, 2024.
What does Invivyd do?
Invivyd was founded in 2022 and is based in Waltham, United States. Drug research and development activities are focused on stem cell targets, alongside clinical trial services within the biotechnology sector. Operations emphasize pharmaceutical innovation through specialized RD support. The board is chaired by Marc Elia, with Ajay Royan serving as a director.
Who are the top competitors of Invivyd?
Invivyd's top competitors include Blue Rock Therapeutics, Ascend and CellCarta.
What products or services does Invivyd offer?
Invivyd offers Antibody Therapies and Invymab.
Is Invivyd publicly traded?
Yes, Invivyd is publicly traded on NASDAQ under the ticker symbol IVVD.
What is Invivyd's ticker symbol?
The ticker symbol of Invivyd is IVVD on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.